Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    Should You Dump AstraZeneca plc In Favour Of GlaxoSmithKline plc?

    | Rupert Hargreaves

    AstraZeneca plc (LON: AZN) currently trades at a premium to GlaxoSmithKline plc (LON: GSK); does it deserve it?

    Read more »

    Investing Articles

    3 Hazardous Reasons To Steer Clear Of AstraZeneca plc

    | Royston Wild

    Royston Wild looks at why AstraZeneca plc (LON: AZN) is an exceptionally risky stock selection.

    Read more »

    Investing Articles

    Can AstraZeneca plc Make £5 Billion Profit?

    | Rupert Hargreaves

    Will AstraZeneca plc (LON: AZN) be able to drive profits higher?

    Read more »

    Investing Articles

    Is AstraZeneca plc Dependent On Debt?

    | Peter Stephens

    Are debt levels at AstraZeneca plc (LON: AZN) becoming detrimental to its future prospects?

    Read more »

    Investing Articles

    GlaxoSmithKline plc Vs AstraZeneca plc — Which Is The Better Bet For Income And Growth?

    | Rupert Hargreaves

    GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:AZN) are both great companies, but which one should you choose?

    Read more »

    Investing Articles

    David & Goliath: AstraZeneca versus Hikma Pharmaceuticals

    | Kevin Godbold

    Which company is most attractive, AstraZeneca or its smaller rival Hikma Pharmaceuticals?

    Read more »

    Company Comment

    The Contrasting Fortunes Of AstraZeneca plc And GlaxoSmithKline plc

    | Mark Stones

    AstraZeneca plc's (LON: AZN) limp results place it in the shadow of rival GlaxoSmithKline plc (LON: GSK).

    Read more »

    Company Comment

    AstraZeneca plc’s Profit Slashed By Half

    | Mark Stones

    Pre-tax profits fell 57% for AstraZeneca plc (LON: AZN) amid competition from copycat drugs.

    Read more »

    Investing Articles

    Why I Sold AstraZeneca plc

    | Tony Reading

    For one Fool, it's time to take profits on AstraZeneca plc (LON:AZN).

    Read more »

    Investing Articles

    Eyes Down For AstraZeneca plc’s Results

    | Alan Oscroft

    It's time to see how 2013 went for AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    5 Ways AstraZeneca plc Could Make You Rich

    | Harvey Jones

    Some investors gave up on AstraZeneca plc (LON: AZN) but history has proved them wrong, says Harvey Jones.

    Read more »

    Investing Articles

    Does AstraZeneca plc Pass My Triple Yield Test?

    | Roland Head

    Finding affordable stocks is getting difficult in today's buoyant market. Does AstraZeneca plc (LON:AZN) fit the bill?

    Read more »